BSE Live
Oct 01, 16:01Prev. Close
1693.25
Open Price
1690.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:51Prev. Close
1691.10
Open Price
1691.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1731.40 (7)
Cash Flow of Epigral (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 540.10 | 290.72 | 522.48 | 383.42 | 160.86 | |
Net CashFlow From Operating Activities | 440.56 | 397.64 | 626.16 | 283.82 | 229.22 | |
Net Cash Used In Investing Activities | -261.56 | -401.10 | -437.22 | -454.63 | -196.73 | |
Net Cash Used From Financing Activities | -163.54 | -7.60 | -199.79 | 195.22 | -31.90 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 15.46 | -11.06 | -10.85 | 24.41 | 0.58 | |
Cash And Cash Equivalents Begin of Year | 3.18 | 14.24 | 25.09 | 0.68 | 0.10 | |
Cash And Cash Equivalents End Of Year | 18.64 | 3.18 | 14.24 | 25.09 | 0.68 |
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
06.05.2025
Epigral Standalone March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y
06.05.2025
Epigral Consolidated March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y